News

Intel Invests Additional $15 Billion In Israeli Chip Facility

Intel’s huge investment comes in addition to the $10 billion already committed by the well-known processor company back in 2019.

Published

2 years ago

June 19, 2023

Nour Nasir

Intel

On Sunday, Israel’s Ministry of Finance announced that the country had reached a new agreement with processor giant Intel that will see $25 billion of investment go towards an updated chip-making facility in Kiryat Gat.

The investment adds another $15 billion on top of the $10 billion earmarked for the proposed factory back in 2019, after the global COVID pandemic delayed construction. The new facility will be significantly more advanced than in the original plans, forming part of a larger production site known as Megafab.

Intel hasn’t yet commented directly on the investment details, but a press release was quick to praise Israeli expertise: “Israel is a global center of technical talent and innovation and one of Intel’s significant global manufacturing and R&D centers. Since its establishment in 1974, Intel Israel has played a crucial role in Intel’s global success. Our intention to expand manufacturing capacity in Israel is driven by our commitment to meeting future manufacturing needs and supporting Intel’s IDM 2.0 strategy, and we appreciate the continued support of the Israeli government”.

Also Read: Dubai Hospital Delivery Drone Completes Successful First Trial

Formal approval of the new agreement is expected to happen in a few weeks as Intel ramps up its international efforts to expand worldwide production capacity. According to a press release from the Israeli finance ministry, thousands of additional technicians will be required in Kiryat Gat, with Intel offering higher wages than the industry average. Additionally, the processor company has agreed to increase its tax obligations from 5% to 7.5%. Intel aims to close the investment deal and commence plant operations by 2027, operating the complex until at least 2035.

As manufacturers like Apple opt to develop their own processor architectures, Intel increasingly needs to adapt to a changing global market worth trillions of dollars. The company’s recent investment in Israel comes shortly after announcing a $4.6 billion deal to build a chip assembly and testing facility in Warsaw, Poland, and joins existing manufacturing facilities in Ireland and Germany.

News

Cemplicity Is Bringing Real-Time Patient Insights To The UAE

The advanced healthcare platform offers tools for chronic disease management and improved patient experiences.

Published

8 hours ago

January 13, 2025

Nour Nasir

Cemplicity

Cemplicity — a leading health-tech company founded in 2013 — has launched its advanced platform in the UAE, aiming to revolutionize patient care and streamline healthcare operations to improve clinical outcomes.

Designed to analyze patient-reported data in real-time, the platform incorporates Patient-Reported Experience Measures (PREMs) and Patient-Reported Outcome Measures (PROMs) to collect and analyze patient feedback. By transforming the data into actionable insights, healthcare providers will be better equipped to improve quality of care and increase efficiency.

Cemplicity’s technology can even tackle chronic conditions like diabetes, which affects 12.3% of the UAE population. By enabling regular symptom tracking and side-effect monitoring (even when patients are at home) the platform ensures proactive care management, and can also optimize early detection and screening of cancers.

Blaik Wilson, Cemplicity’s CEO, shared: “We are excited to bring Cemplicity to the UAE, a nation committed to healthcare excellence. With the private healthcare sector evolving at an impressive pace, partnering with such forward-thinking providers enables us to transform patient feedback into meaningful insights that enhance patient experiences and improve outcomes”.

Wilson added: “Globally, healthcare produces 30% of the world’s data volume. Aggregating and anonymizing patient-reported data not only uncovers trends and evaluates treatment outcomes but also advances the UAE’s broader ambition to lead in medical research and innovation”.

Also Read: Malak Trabelsi Loeb On Leadership And QIS 2025

With a presence in nine countries and partnerships with major healthcare providers like the UK’s National Health Service (NHS), Cemplicity has already redefined how hospitals and clinics leverage patient feedback. Its tools, known for achieving high survey response rates, help link patient experiences to organizational KPIs and Net Promoter Scores (NPS), enabling measurable improvements in operations, and clinical outcomes, while fostering a culture of continuous improvement.

For the UAE market, the platform has been specially adapted to local needs, offering multilingual support (including Arabic) and seamless integration with tools such as WhatsApp and various hospital management systems.